Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Cocklin

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Journal of the American Chemical Society|February 23, 2012
A carrier protein strategy yields the structure of dalbavancinNicoleta J Economou, Virginie Nahoum, Stephen D Weeks, et al.
Chemmedchem|January 31, 2013
Identification of a small-molecule inhibitor of HIV-1 assembly that targets the phosphatidylinositol (4,5)-bisphosphate binding site of the HIV-1 matrix proteinIsaac Zentner, Luz-Jeannette Sierra, Ayesha K Fraser, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Discovery of novel brain permeable human ACSS2 inhibitors for blocking breast cancer brain metastatic growthEmily Esquea, Lorela Ciraku, Riley G Young, et al.
The Journal of Biological Chemistry|August 15, 2002
PDZ domains facilitate binding of high temperature requirement protease A (HtrA) and tail-specific protease (Tsp) to heterologous substrates through recognition of the small stable RNA A (ssrA)-encoded peptideAlison Spiers, Heather K Lamb, Simon Cocklin, et al.
European Journal of Medicinal Chemistry|February 18, 2020
Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activitiesLin Sun, Tianguang Huang, Alexej Dick, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid ModulatorsXujie Zhang, Lin Sun, Shujing Xu, et al.
Bioorganic & Medicinal Chemistry|September 25, 2021
Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitorsJing Li, Xiangyi Jiang, Alexej Dick, et al.
European Journal of Medicinal Chemistry|September 23, 2018
Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound libraryGaochan Wu, Waleed A Zalloum, Megan E Meuser, et al.
Journal of Immunological Methods|March 29, 2025
Identification of polyreactive antibodies by high throughput enzyme-linked immunosorbent assay and surface Plasmon resonanceLuis Antonio Rodriguez Carnero, Daniel Bedinger, Simon Cocklin, et al.
Biochemistry|February 18, 2004
Mode of action for linear peptide inhibitors of HIV-1 gp120 interactionsAlyssa C Biorn, Simon Cocklin, Navid Madani, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Journal of the American Chemical Society|February 23, 2012
A carrier protein strategy yields the structure of dalbavancinNicoleta J Economou, Virginie Nahoum, Stephen D Weeks, et al.
Chemmedchem|January 31, 2013
Identification of a small-molecule inhibitor of HIV-1 assembly that targets the phosphatidylinositol (4,5)-bisphosphate binding site of the HIV-1 matrix proteinIsaac Zentner, Luz-Jeannette Sierra, Ayesha K Fraser, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Discovery of novel brain permeable human ACSS2 inhibitors for blocking breast cancer brain metastatic growthEmily Esquea, Lorela Ciraku, Riley G Young, et al.
The Journal of Biological Chemistry|August 15, 2002
PDZ domains facilitate binding of high temperature requirement protease A (HtrA) and tail-specific protease (Tsp) to heterologous substrates through recognition of the small stable RNA A (ssrA)-encoded peptideAlison Spiers, Heather K Lamb, Simon Cocklin, et al.
European Journal of Medicinal Chemistry|February 18, 2020
Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activitiesLin Sun, Tianguang Huang, Alexej Dick, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid ModulatorsXujie Zhang, Lin Sun, Shujing Xu, et al.
Bioorganic & Medicinal Chemistry|September 25, 2021
Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitorsJing Li, Xiangyi Jiang, Alexej Dick, et al.
European Journal of Medicinal Chemistry|September 23, 2018
Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound libraryGaochan Wu, Waleed A Zalloum, Megan E Meuser, et al.
Journal of Immunological Methods|March 29, 2025
Identification of polyreactive antibodies by high throughput enzyme-linked immunosorbent assay and surface Plasmon resonanceLuis Antonio Rodriguez Carnero, Daniel Bedinger, Simon Cocklin, et al.
Biochemistry|February 18, 2004
Mode of action for linear peptide inhibitors of HIV-1 gp120 interactionsAlyssa C Biorn, Simon Cocklin, Navid Madani, et al.
Pageof 8